Hughes Financial Services’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Other funds holding APLS
Hughes Financial Services's APLS Position: Q2 2026 in Review
Hughes Financial Services sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 1 share — an estimated $40 sold.
Hughes Financial Services first reported a position in APLS in Q4 2025 and held it in 2 quarters. The position peaked at $1.78K in Q4 2025. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- Hughes Financial Services reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Hughes Financial Services sold 1 Apellis Pharmaceuticals share in Q2 2026, an estimated $40.
- Hughes Financial Services first reported a position in Apellis Pharmaceuticals in Q4 2025 and held it in 2 quarters.
- Hughes Financial Services's Apellis Pharmaceuticals position peaked at $1.78K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.